Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3067% below fair value
$0.71+0.08 (+12.14%)
Close on Nov 18, 2026Market cap $5.36MP/E –Yield –
Cerenome total assets
Total assets on the balance sheet at the end of each period.
Cerenome's total assets was $14.03M at Jun 30, 2026. For fiscal 2025 it was $16.33M, up 146.1% from the year before. Over ten years it grew -8.0% a year on average. The highest annual figure on record is $66.35M in fiscal 2010.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.33M | +146.1% |
| FY2024 | Dec 31, 2024 | $6.63M | -41.8% |
| FY2023 | Dec 31, 2023 | $11.39M | -52.3% |
| FY2022 | Dec 31, 2022 | $23.87M | +8.6% |
| FY2021 | Dec 31, 2021 | $21.98M | +81.6% |
| FY2020 | Dec 31, 2020 | $12.11M | -47.9% |
| FY2019 | Dec 31, 2019 | $23.23M | -3.2% |
| FY2018 | Dec 31, 2018 | $23.99M | -24.1% |
| FY2017 | Dec 31, 2017 | $31.62M | -8.7% |
| FY2016 | Dec 31, 2016 | $34.61M | -8.2% |
| FY2015 | Dec 31, 2015 | $37.70M | -2.6% |
| FY2014 | Dec 31, 2014 | $38.72M | -7.9% |
| FY2013 | Dec 31, 2013 | $42.06M | -2.8% |
| FY2012 | Dec 31, 2012 | $43.25M | -16.1% |
| FY2011 | Dec 31, 2011 | $51.53M | -22.3% |
| FY2010 | Dec 31, 2010 | $66.35M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.03M | +35.6% |
| Q1 FY2026 | Mar 31, 2026 | $19.92M | +65.2% |
| Q4 FY2025 | Dec 31, 2025 | $16.33M | +146.1% |
| Q3 FY2025 | Sep 30, 2025 | $18.67M | +167.6% |
| Q2 FY2025 | Jun 30, 2025 | $10.35M | -7.7% |
| Q1 FY2025 | Mar 31, 2025 | $12.06M | +114.5% |
| Q4 FY2024 | Dec 31, 2024 | $6.63M | -41.8% |
| Q3 FY2024 | Sep 30, 2024 | $6.98M | -47.4% |
| Q2 FY2024 | Jun 30, 2024 | $11.21M | -21.0% |
| Q1 FY2024 | Mar 31, 2024 | $5.62M | -64.1% |
| Q4 FY2023 | Dec 31, 2023 | $11.39M | -52.3% |
| Q3 FY2023 | Sep 30, 2023 | $13.28M | -42.5% |
| Q2 FY2023 | Jun 30, 2023 | $14.20M | -33.3% |
| Q1 FY2023 | Mar 31, 2023 | $15.64M | -36.2% |
| Q4 FY2022 | Dec 31, 2022 | $23.87M | +8.6% |
| Q3 FY2022 | Sep 30, 2022 | $23.10M | -6.7% |
| Q2 FY2022 | Jun 30, 2022 | $21.27M | +2.1% |
| Q1 FY2022 | Mar 31, 2022 | $24.52M | +33.7% |
| Q4 FY2021 | Dec 31, 2021 | $21.98M | +81.6% |
| Q3 FY2021 | Sep 30, 2021 | $24.75M | +112.4% |
| Q2 FY2021 | Jun 30, 2021 | $20.83M | +49.8% |
| Q1 FY2021 | Mar 31, 2021 | $18.34M | -12.5% |
| Q4 FY2020 | Dec 31, 2020 | $12.11M | -47.9% |
| Q3 FY2020 | Sep 30, 2020 | $11.65M | -54.7% |
| Q2 FY2020 | Jun 30, 2020 | $13.90M | +56.5% |
| Q1 FY2020 | Mar 31, 2020 | $20.97M | -14.8% |
| Q4 FY2019 | Dec 31, 2019 | $23.23M | -3.2% |
| Q3 FY2019 | Sep 30, 2019 | $25.72M | +0.7% |
| Q2 FY2019 | Jun 30, 2019 | $8.88M | -66.7% |
| Q1 FY2019 | Mar 31, 2019 | $24.62M | -22.1% |
| Q4 FY2018 | Dec 31, 2018 | $23.99M | -9.3% |
| Q3 FY2018 | Sep 30, 2018 | $25.53M | -21.4% |
| Q1 FY2018 | Mar 31, 2018 | $26.64M | -10.5% |
| Q4 FY2017 | Dec 31, 2017 | $31.62M | -8.7% |
| Q3 FY2017 | Sep 30, 2017 | $26.45M | -28.2% |
| Q2 FY2017 | Jun 30, 2017 | $32.48M | -23.9% |
| Q1 FY2017 | Mar 31, 2017 | $29.77M | – |
| Q4 FY2016 | Dec 31, 2016 | $34.61M | – |
| Q3 FY2016 | Sep 30, 2016 | $36.84M | – |
| Q2 FY2016 | Jun 30, 2016 | $42.68M | – |
See a number that looks wrong?